LANXESS to unveil new Rely+On Medero disinfectant at Medica trade fair

LANXESS will launch its new broad-spectrum disinfectant Rely+On Medero at Medica 2026, taking place November 16–19 in Düsseldorf, where it will also showcase its Rely+On infection-prevention portfolio and active ingredients for disinfectant formulation. The product is based on Potassium Monopersulfate (Oxone) and in-situ generated active chlorine, is approved as a medical-device disinfectant under EU Class IIa, and is authorised as Product Type II under the Biocidal Products Regulation for non-medical hard surfaces.

Key facts

Market context

Potassium monopersulfate, sold commercially as Oxone, is a powerful oxidant and a widely used active in surface and instrument disinfectants, bleaching and chemical synthesis. Active chlorine compounds are another established biocidal oxidizer used against bacteria, viruses and spores. Demand for disinfectants of this kind is driven mainly by healthcare, where hospitals, intensive care units, isolation rooms and medical device reprocessing require validated hard-surface and instrument cleaning. Public sector facilities and institutional cleaning contractors form a second demand pool. Regulatory approval is central to commercial access: medical-device disinfectants are classed under EU medical device rules, while non-medical surface products fall under the Biocidal Products Regulation with product-type authorisations. Suppliers of active ingredients and formulated products compete on efficacy, material compatibility, approvals and supply reliability, and infection-control trade fairs are a common venue for launching such products.

Source: official release on lanxess.com. Summary and context written by Market Krystal.